“…Discovery of cis-platin by Rosenberg [55] and its new marketing analogues (carboplatin, lobaplatin, oxaliplatin, nedaplatin) have further created interest in metal-based anticancer drugs [1,56]. Tin complexes have been studied in detail as antibacterial agents [9,15,[17][18][19]28] and recently against cancerous cell lines [12,26,57] other than colon cancer. In the current study, complexes 1-2 were tested against three cancerous cell lines (human colon cancer HCT 116, breast cancer MCF-7, leukemia K562) and a non-cancerous cell line (3T3-L1).…”